Terms: = Head and neck cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
119 results:
1. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
2. Gene sequencing applications to combat oral-cavity related disorders: a systematic review with meta-analysis.
Abdul NS; Shenoy M; Reddy NR; Sangappa SB; Shivakumar GC; Di Blasio M; Cicciù M; Minervini G
BMC Oral Health; 2024 Jan; 24(1):103. PubMed ID: 38233799
[TBL] [Abstract] [Full Text] [Related]
3. Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients.
Kim S; Lim JH; Kim CH; Roh J; You S; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Heo J
Sci Rep; 2024 Jan; 14(1):922. PubMed ID: 38195717
[TBL] [Abstract] [Full Text] [Related]
4. Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
Wang X; Zeng M; Ju X; Lin A; Zhou C; Shen J; Liu Z; Tang B; Cheng Q; Wang Y; Zhang J; Luo P
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38055899
[TBL] [Abstract] [Full Text] [Related]
5. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
6. Experience with the management of 2599 cases of congenital muscular torticollis and a multicenter epidemiological investigation in 17 hospitals in China.
Zhao Z; Deng H; Li Y; Wang X; Tang G; Zeng Y; Xu H; Yang Q; Wu Z; Li S; Cui Z; Feng G; Fu G; Tang S; Xiong Z; Qiu X;
BMC Musculoskelet Disord; 2023 Nov; 24(1):901. PubMed ID: 37980469
[TBL] [Abstract] [Full Text] [Related]
7. A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
Kanankulam Velliangiri S; Ballal S; Prasad Yadhav M; Tripathi M; Satapathy S; Bal C
PLoS One; 2023; 18(11):e0294343. PubMed ID: 37963164
[TBL] [Abstract] [Full Text] [Related]
8. Preventable burden of head and neck cancer attributable to tobacco and alcohol between 1990 and 2039 in China.
Song C; Chen Y; Qiao Y
Cancer Sci; 2023 Aug; 114(8):3374-3384. PubMed ID: 37302807
[TBL] [Abstract] [Full Text] [Related]
9. Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011-2019 NPCR and SEER incidence data.
Zhang W; Bai Y; Sun C; Lv Z; Wang S
Front Public Health; 2022; 10():1058722. PubMed ID: 36530732
[TBL] [Abstract] [Full Text] [Related]
10. Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.
Cao YF; Xie L; Tong BB; Chu MY; Shi WQ; Li X; He JZ; Wang SH; Wu ZY; Deng DX; Zheng YQ; Li ZM; Xu XE; Liao LD; Cheng YW; Li LY; Xu LY; Li EM
Cell Death Differ; 2023 Feb; 30(2):527-543. PubMed ID: 36526897
[TBL] [Abstract] [Full Text] [Related]
11. GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis.
Xi Y; Zhang T; Sun W; Liang R; Ganesh S; Chen H
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499755
[TBL] [Abstract] [Full Text] [Related]
12. Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [
Dongxiang W; Liting L; Yujing L; Meijuan L; Shanshan G; Longbin X; Yanzhou C; Meiling C; Kang N; Haiqiang M; Linquan T; Qiuyan C
Eur Radiol; 2023 Apr; 33(4):2840-2849. PubMed ID: 36422647
[TBL] [Abstract] [Full Text] [Related]
13. Cribriform - morular thyroid carcinoma: a rare entity.
Michnová U; Traboulsi E; Peková B; Ryška A
Cesk Patol; 2022; 58(2):107-110. PubMed ID: 35882545
[TBL] [Abstract] [Full Text] [Related]
14. Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal cancer in a Low-Burden Region of Southern Europe.
Rubió-Casadevall J; Ciurana E; Puigdemont M; Sanvisens A; Marruecos J; Miró J; Urban A; Palhua RL; Martín-Romero F; Ortiz-Duran MR; Marcos-Gragera R
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457669
[No Abstract] [Full Text] [Related]
15. Incidence and Survival of Oral Cavity and Oropharyngeal cancer in the United States From 1975 to 2018.
Cheng J; Zhou X; Xu H; Dan H; Li J; Chen Q
J Oral Maxillofac Surg; 2022 Jul; 80(7):1294-1305. PubMed ID: 35447078
[TBL] [Abstract] [Full Text] [Related]
16. Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.
Prasad M; Ponnalagu S; Zeng Q; Luu K; Lang SM; Wong HY; Cheng MS; Wu M; Mallilankaraman K; Sobota RM; Lim YT; Wang LC; Goh CK; Tay KXJ; Loh KS; Wang CI; Lee WH; Goh BC; Lim CM; Schwarz H
Cancer Immunol Immunother; 2022 Nov; 71(11):2583-2596. PubMed ID: 35299256
[TBL] [Abstract] [Full Text] [Related]
17. Central Compartment Lymph Nodes Have Distinct Metastatic Patterns in Different Age Groups.
Yan C; He X; Chen Z; Wang Y
Front Endocrinol (Lausanne); 2022; 13():807431. PubMed ID: 35250865
[TBL] [Abstract] [Full Text] [Related]
18. CYLD deficiency enhances metabolic reprogramming and tumor progression in nasopharyngeal carcinoma via PFKFB3.
Wang L; Lin Y; Zhou X; Chen Y; Li X; Luo W; Zhou Y; Cai L
Cancer Lett; 2022 Apr; 532():215586. PubMed ID: 35131382
[TBL] [Abstract] [Full Text] [Related]
19. Pulmonary epithelial-myoepithelial carcinoma (P-EMC) with focal high grade transformation: Molecular and cytologic findings.
Charles R; Murray S; Gray E; Hu J
Diagn Cytopathol; 2022 Jun; 50(6):E156-E162. PubMed ID: 35100487
[TBL] [Abstract] [Full Text] [Related]
20. Incidence and prognosis of thyroid cancer in children: based on the SEER database.
Zhang B; Wu W; Shang X; Huang D; Liu M; Zong L
Pediatr Surg Int; 2022 Mar; 38(3):445-456. PubMed ID: 35091762
[TBL] [Abstract] [Full Text] [Related]
[Next]
